PD-RX Pharmaceuticals (PDRX) Stock Statistics & Valuation Metrics
Total Valuation
PD-RX Pharmaceuticals has a market cap or net worth of $4.79M. The enterprise value is -$2.44T.
- Market Cap
- $4.79M
- Enterprise Value
- -$2.44T
Share Statistics
PD-RX Pharmaceuticals has 1,545,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,545,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PD-RX Pharmaceuticals’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -4.28%.
- Return on Equity (ROE)
- -0.03
- Return on Assets (ROA)
- -0.02
- Return on Invested Capital (ROIC)
- -4.28%
- Return on Capital Employed (ROCE)
- -0.05
- Revenue Per Employee
- 129.22K
- Profits Per Employee
- -1,813.542
- Employee Count
- 142
- Asset Turnover
- 1.53
- Inventory Turnover
- 7.20
Income Statement
In the last 12 months, PD-RX Pharmaceuticals had revenue of 18.35M and earned -257.52K in profits. Earnings per share was -0.17.
- Revenue
- 18.35M
- Gross Profit
- 5.43M
- Operating Income
- -477.42K
- Pretax Income
- -278.74K
- Net Income
- -257.52K
- EBITDA
- -327.97K
- Earnings Per Share (EPS)
- -0.17
Dividends & Yields
PD-RX Pharmaceuticals pays an annual dividend of $2.20, resulting in a dividend yield of ―
- Dividend Per Share
- $2.20
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- ―
- Earnings Yield
- ―
Stock Price Statistics
- Beta
- 0.09
- 52-Week Price Change
- 10.71%
- 50-Day Moving Average
- 3.12
- 200-Day Moving Average
- 3.29
- Relative Strength Index (RSI)
- 0.01
- Average Volume (3m)
- 759
Important Dates
PD-RX Pharmaceuticals upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- ―
- Next Earnings Date
- ―
- Ex-Dividend Date
- Dec 13, 2018
Financial Position
PD-RX Pharmaceuticals as a current ratio of 6.34, with Debt / Equity ratio of 0.00%
- Current Ratio
- 6.34
- Quick Ratio
- 5.27
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 18.80
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, PD-RX Pharmaceuticals has paid -21.22K in taxes.
- Income Tax
- -21.22K
- Effective Tax Rate
- 0.08
Analyst Forecast
The average price target for PD-RX Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
